Related Experiment Video
Updated: Feb 8, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Hemorrhagic Moyamoya Disease Treatment: A Network Meta-Analysis
Jiayue Ding1, Da Zhou1, Eric Eugene Paul Cosky2
1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China; China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China; Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
Background:
Therapeutic strategies for managing hemorrhagic moyamoya disease (MMD) remain controversial. In this study, we investigated the optimal therapy for hemorrhagic MMD.
Methods:
In accordance with the PRISMA statement, we searched through relevant articles and references from PubMed, Embase, and Cochrane database, and performed a network meta-analysis using R version 3.4.4 software.
Results:
A total of 9 articles (including 1050 patients) were included in our analysis. Of these 1050 patients, 557 underwent surgical revascularization (including direct and indirect bypass), and the remaining 493 patients were managed with a conservative treatment regimen. A pooled analysis revealed that surgical revascularization was superior to the conservative treatment regimen in decreasing the rate of recurrent stroke events (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.24-0.65), including ischemic stroke recurrence (OR, 0.31; 95% CI, 0.12-0.79) and hemorrhage recurrence (OR, 0.45; 95% CI, 0.26-0.79), but not in reducing mortality (OR, 0.53; 95% CI, 0.24-1.17). Moreover, the incidence of recurrent stroke in the direct bypass cohort was lower than that for either the conservative treatment cohort (OR, 0.30; 95% CI, 0.15-0.58) or the indirect bypass cohort (OR, 0.39; 95% CI, 0.18-0.87). However, the ratios showed no statistically significant difference between the latter 2 cohorts (OR, 0.75; 95% CI, 0.33-1.68).
Conclusions:
Surgical revascularization, especially a direct bypass regimen, may be the optimal strategy for treating hemorrhagic MMD.
Insights
Surgical revascularization, particularly direct bypass, is more effective than conservative treatment for preventing recurrent strokes in hemorrhagic moyamoya disease (MMD). It reduces both ischemic and hemorrhagic stroke recurrence but does not impact mortality rates.
Area of Science:
- Neurosurgery
- Neurology
- Vascular Surgery
Background:
- Hemorrhagic moyamoya disease (MMD) management strategies are debated.
- Optimal therapy for MMD with hemorrhage requires further investigation.
Purpose of the Study:
- To investigate the optimal therapeutic strategy for hemorrhagic moyamoya disease.
- To compare the efficacy of surgical revascularization versus conservative treatment.
Main Methods:
- A systematic literature search was conducted using PRISMA guidelines across PubMed, Embase, and Cochrane databases.
- A network meta-analysis of 9 articles, including 1050 patients, was performed using R software.
Main Results:
- Surgical revascularization significantly reduced recurrent stroke events (OR, 0.39) compared to conservative treatment.
- Direct bypass surgery showed a lower incidence of recurrent stroke than conservative or indirect bypass (OR, 0.30 and 0.39, respectively).
- Surgical revascularization did not significantly reduce mortality (OR, 0.53).
Conclusions:
- Surgical revascularization, especially direct bypass, is suggested as the optimal strategy for hemorrhagic MMD.
- Direct bypass appears superior to indirect bypass and conservative management in preventing recurrent strokes.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein Networks
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Directing Effect of Substituents: meta-Directing Groups

